Recruiting now—Ages 18 Years and up
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Sponsor: UNC Lineberger Comprehensive Cancer Center · NCT05743426 on ClinicalTrials.gov ↗
Conditions studied
SarcomaGastrointestinal Cancer
What it tests
- Surveyother
- Toxicity Assessmentsother
Where it's running1 site
- Recruiting now
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, North Carolina 27599
- Victoria Xu(contact)984-974-8744[email protected]
- Theodore K Yanagihara, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria In order to participate in this study a subject must meet all of the eligibility criteria outlined below. 1. Subject is willing and able to provide written informed consent to participate in the study and HIPAA authorization for the release of personal health information. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designer. 2. Age ≥ 18 years at the time of consent. 3. Histological, cytological, or radiographic evidence/confirmation of a gastrointestinal malignancy or sarcoma. 4. Females with childbearing potential and male subjects with fathering potential are allowed to participate in this study. Exclusion Criteria All subjects meeting any exclusion criteria at baseline will be excluded from study participation. 1. Inability or unwillingness to provide informed consent 2. Patients who state they do not expect to be available or willing to follow up at expected intervals post-treatment
Updated 2026-03-30 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.